MIPS eligible clinicians must implement at least one process improvement during treatment of patients taking anti-psychotic medication related to one or more component(s) of appropriate antipsychotic medication assessment and monitoring. Components include: • Personal and family history of obesity, diabetes, dyslipidemia, hypertension, or cardiovascular disease; • Body Mass Index (BMI); • Waist circumference; • Blood pressure; • Fasting plasma glucose; • Fasting lipid profile; • Clinical assessment of abnormal movements, such as through the Abnormal Involuntary Movement Scale (AIMS). Process improvements must include at least one of the following types of activities: • Establishing and disseminating educational materials (for example, online or in-person training sessions) to educate clinical teams about physical health monitoring and protocols for monitoring (for example, AIMS assessment for medication-induced movement disorders); • Creating and implementing monitoring templates and protocols (for example, EHR-integrated flags), to standardize collection and documentation of one or more components of physical health monitoring; or • Establishing collaborative service agreements with an enhanced monitoring service, (for example, pharmacist-led monitoring clinic) to monitor for antipsychotic associated physical health condition and either adjust medications (for example, diabetes medications) based on laboratory results or refer patients for further assessments (for example, AIMS).”